中山醫學大學機構典藏 CSMUIR:Item 310902500/11260
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 17901/22917 (78%)
造访人次 : 7599242      在线人数 : 226
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧:
  • 您可在西文检索词汇前后加上"双引号",以获取较精准的检索结果
  • 若欲以作者姓名搜寻,建议至进阶搜寻限定作者字段,可获得较完整数据
  • 进阶搜寻


    jsp.display-item.identifier=請使用永久網址來引用或連結此文件: https://ir.csmu.edu.tw:8080/ir/handle/310902500/11260


    题名: 阿斯匹林在初級預防中的最佳應用--族群和劑量的選擇=The Best Usage of Aspirin in Primary Prevention--Indication, Dosage and Ethnic Issues
    作者: 林中生
    許惠恒
    陳昌明
    吳造中
    何橈通
    許重義
    徐粹烈
    盧玉強
    陳明豐
    贡献者: 中山醫學大學
    关键词: 阿斯匹林;中風;劑量;糖尿病;代謝綜合症;初級預防;Aspirin;Stroke;Dosage;Diabetes;Metabolic syndrome;Primary prevention
    日期: 2007
    上传时间: 2015-07-14T10:45:22Z (UTC)
    摘要: Aspirin is a well-known drug applied in clinical therapy. However, results of aspirin researches and clinical trials are different from traditional therapeutical guidelines. Some new conclusions emerged. Aspirin takes in a prevention role in some diseases, such as cardiovascular (CV) events, diabetes, and metabolic syndrome. However, how to apply aspirin in primary prevention still needs more discussion. In this article, we discuss the effect of aspirin in the field of cardiology, stroke, diabetes and pharmacology. We also discuss the dosage and appropriate usage of aspirin in Taiwan's population. The content of this article included the view points of the benefit of aspirin in the prevention of CV events from cardiologist's, diabetologist's and neurologist's view. We also discuss the starring role of aspirin from pharmacological issues or clinical reality? The conclusions are that enteric-coated aspirin has good gastrointestinal tolerability than common caplets; Anti-platelet therapies such as long-term use of low dose aspirin (75-150 mg/day) can significantly reduce cardiovascular events; Aspirin can reduce the risk of first stroke in women and myocardial infarction in man; It also can reduce the risk of cardiovascular events in diabetes. Besides, American Heart Association and American Diabetes Association recommend that aspirin can be used as primary and secondary prevention in high risk population of cardiovascular disease. The individual management is recommended when people who have high risk of CV events and use aspirin in primary or secondary prevention.
    URI: https://ir.csmu.edu.tw:8080/ir/handle/310902500/11260
    關聯: 內科學誌 18:1 2007.02[民96.02] 頁1-10
    显示于类别:[醫學系] 期刊論文

    文件中的档案:

    档案 描述 大小格式浏览次数
    index.html期刊論文0KbHTML340检视/开启


    SFX Query

    在CSMUIR中所有的数据项都受到原著作权保护.

    TAIR相关文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈